Given the critical role of CaV1.2 in beta cell signaling and the marked frequency of hypoglycemia in patients with TS, CACNA1C is a promising candidate gene for screening patients with congenital hyperinsulinism (CHI). Here, CACNA1C is linked to familial hyperinsulinism.